Original Article
Journal of Human Hypertension (2007) 21, 347–352. doi:10.1038/sj.jhh.1002133; published online 2 March 2007
Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study
G Bakris1, M Dickholtz Sr2, P M Meyer1, G Kravitz1, E Avery1, M Miller3, J Brown3, C Woodfield4 and B Bell3
- 1Department of Preventive Medicine, Rush University Hypertension Center, Chicago, IL, USA
- 2Chiropractic Health Center, Chicago, IL, USA
- 3Barrington Family Medical Clinic, Barrington, IL, USA
- 4Atlas Research Foundation, Barrington, IL, USA
Correspondence: Professor G Bakris, Department of Medicine, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Avenue, MC 1027, Room 267, Chicago, IL 60637, USA. E-mail:gbakris@earthlink.net
Received 27 July 2006; Revised 28 September 2006; Accepted 28 September 2006; Published online 2 March 2007.
Abstract
Anatomical abnormalities of the cervical spine at the level of the Atlas vertebra are associated with relative ischaemia of the brainstem circulation and increased blood pressure (BP). Manual correction of this mal-alignment has been associated with reduced arterial pressure. This pilot study tests the hypothesis that correcting mal-alignment of the Atlas vertebra reduces and maintains a lower BP. Using a double blind, placebo-controlled design at a single center, 50 drug naïve (n=26) or washed out (n=24) patients with Stage 1 hypertension were randomized to receive a National Upper Cervical Chiropractic (NUCCA) procedure or a sham procedure. Patients received no antihypertensive meds during the 8-week study duration. The primary end point was changed in systolic and diastolic BP comparing baseline and week 8, with a 90% power to detect an 8/5 mm Hg difference at week 8 over the placebo group. The study cohort had a mean age 52.7
9.6 years, consisted of 70% males. At week 8, there were differences in systolic BP (-17
9 mm Hg, NUCCA versus -3
11 mm Hg, placebo; P<0.0001) and diastolic BP (-10
11 mm Hg, NUCCA versus -2
7 mm Hg; P=0.002). Lateral displacement of Atlas vertebra (1.0, baseline versus 0.04° week 8, NUCCA versus 0.6, baseline versus 0.5°, placebo; P=0.002). Heart rate was not reduced in the NUCCA group (-0.3 beats per minute, NUCCA, versus 0.5 beats per minute, placebo). No adverse effects were recorded. We conclude that restoration of Atlas alignment is associated with marked and sustained reductions in BP similar to the use of two-drug combination therapy.
Keywords:
atlas, vertebra, antihypertensive therapy
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Journal of Human Hypertension Original Article
Cruciate paralysis and hemiplegia cruciata: report of three cases
Spinal Cord Correspondence
Abnormal bony protuberance of anterior atlas causing dysphagia. A rare congenital anomaly
Spinal Cord Correspondence
Spinal Cord Correspondence
